RELIEF THERAPEUTICS HLDG AG (RLFTF, $2.81) was a top loser over the last three months, falling -2 to $2.81 per share. A.I.dvisor analyzed 841 stocks in the Biotechnology Industry for the 3-month period ending May 5, 2025, and found that of them (2) exhibited an Uptrend while of them (7) demonstrated a Downtrend.